Search Results
Dec 19, 2025, 03:00 ET The CHMP adopted a positive opinion for Vueway® (gadopiclenol) for its use in pediatric patients under 2 years of age
Pharmacokinetic Profiles of Gadopiclenol: A New Macrocyclic Gadolinium Chelate With High T1 Relaxivity. Invest Radiol 2019; 54(8):475-484.Hao J, Pitrou C, Bourrinet P. A Comprehensive Overview of the Efficacy and Safety of Gadopiclenol: A New Contrast Agent for MRI of the CNS and Body. Invest
More news about: Bracco Group
Dec 18, 2025, 23:16 ET Milu: The Name Returns
full story of how a lost species—and its name—found its way home.http://bit.ly/4j2ZfU7
More news about: Hubei Daily
Dec 18, 2025, 17:50 ET E-Chem Launches EPX50-RC: A High-Performance Epoxy Overlay System for Bridge Deck Preservation and Increased Pavement Skid Resistance
conditions."EPX50-RC was developed in direct response to contractor feedback and the growing need for faster, more durable overlay systems," said T. J. Bland, Commercial President of Meridian's Infrastructure Division. "It's about maximizing uptime and safety, while extending the lifespan of our nation's
More news about: Meridian Adhesives Group
Dec 18, 2025, 17:30 ET Primis Financial Corp. Announces Reauthorization of Stock Repurchase Program
Address:Dennis J. Zember, Jr., President and CEOPrimis Financial
More news about: Primis Financial Corp.
Dec 18, 2025, 16:39 ET AdvisorShares Issues Statement on Executive Order to Reclassify Cannabis
sponsor of actively managed exchange-traded funds (ETFs), today issued the following statement in response to the Executive Order by President Donald J. Trump directing federal agencies to advance the reclassification of cannabis under the Controlled Substances Act.
More news about: AdvisorShares
Dec 18, 2025, 14:26 ET ANVISA aprova Metalyse® 25mg da Boehringer Ingelheim para o tratamento de AVC isquêmico agudo
520-27.Mahawish K, et al. Stroke 2021; 52: e590-e593.Alamowitch S, et al. Eur Stroke J. 2023; 8(1): 8-54.Warach SJ and Saver JL. JAMA Neurol. 2020;77(10): 1203-1204.Heran M, et al. Can J Neurol Sci. 2022; 19: 1-94.Stroke Foundation. Diretrizes clínicas para tratamento
More news about: Boehringer Ingelheim
Dec 18, 2025, 14:00 ET Italian Gold Broker in $86M Customs Duty and Tariff Evasion Case Released on Bail
in an alleged $86 million customs duty and tariff evasion scheme, has been released on bail following an application filed in federal court by his attorney, Anthony J. Mahajan of Health Law Alliance.
More news about: Health Law Alliance
Dec 18, 2025, 12:40 ET OWL Investors Encouraged to Seek Lead Plaintiff Role in Blue Owl Capital Inc. Securities Fraud Case with Johnson Fistel
this promotional communication, and Frank J. Johnson is the attorney responsible for its content.Contact:Johnson Fistel, PLLP501 W. Broadway, Suite 800, San Diego, CA 92101James Baker, Investor Relations, or Frank J. Johnson, Esq.(619) 814-4471
More news about: Johnson Fistel, PLLP
Dec 18, 2025, 12:35 ET Klarna Group plc (NYSE: KLAR): Johnson Fistel Investigates Post-Earnings Disclosures Following Significant Stock Decline Since the IPO
performed by attorneys in any of our offices.Johnson Fistel, PLLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.Contact:Johnson Fistel, PLLP501 W. Broadway, Suite 800, San Diego,
More news about: Johnson Fistel, PLLP
Dec 18, 2025, 12:33 ET DEFT Investors Encouraged to Seek Lead Plaintiff Role in DeFi Technologies Securities Fraud Case with Johnson Fistel
this promotional communication, and Frank J. Johnson is the attorney responsible for its content.Contact:Johnson Fistel, PLLP501 W. Broadway, Suite 800, San Diego, CA 92101James Baker, Investor Relations, or Frank J. Johnson, Esq.(619) 814-4471
More news about: Johnson Fistel, PLLP
Dec 18, 2025, 12:00 ET Bitdeer Technologies Group (BTDR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
2024 and November 10, 2025, Defendants failed to disclose to investors that: (1) the SEAL04 chip projected to have a chip-level energy efficiency of 5 J/TH would be ready for use in the A4 rigs with an expected mass production to begin in the second quarter 2025; and (2) as a result, Defendants' positive
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Dec 18, 2025, 11:53 ET KRAUSE GROUP RELEASES 2024 CORPORATE SOCIAL RESPONSIBILITY REPORT
"At Krause Group, we believe that creating lasting value and driving positive societal impact go hand in hand," said Kyle J. Krause, Founder & CEO of Krause Group. "Our CSR report is a reflection of the values that guide us every day, holding us accountable, leading by
More news about: Krause Group
Dec 18, 2025, 11:36 ET Johnson Fistel Investigates Potential Fiduciary Breaches in Electronic Arts $210/Share Go-Private Deal
performed by attorneys in any of our offices.Johnson Fistel, PLLP, has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.Contact:Johnson Fistel, PLLPJames Baker501 W. Broadway,
More news about: Johnson Fistel, PLLP
Dec 18, 2025, 11:34 ET Johnson Fistel Investigates the Grindr Board for Potential Breaches of Fiduciary Duties Relating to the Grindr Buyout Termination
this promotional communication, and Frank J. Johnson is the attorney responsible for its content.ContactJohnson Fistel, PLLP501 W. Broadway, Suite 800San Diego, CA 92101James Baker, Investor Relations – or – Frank J. Johnson, Esq.(619) 814-4471 |
More news about: Johnson Fistel, PLLP
Dec 18, 2025, 11:09 ET MOBILion Systems demuestra un nuevo paradigma en proteómica basada en espectrometría de masas
específicamente, la ineficiencia inherente en el uso de iones que se intensifica a medida que aumenta la complejidad analítica (Hoaglund-Hyzer CS, Li J, Clemmer DE. Analytical Chemistry. 2000;72(13):2737–2740). A pesar de los avances en instrumentación y software, el campo se ha mantenido limitado a ganancias
More news about: MOBILion Systems
Dec 18, 2025, 10:55 ET JAECOO J7 consolida su competitividad global con reconocimientos internacionales en Europa, Asia y América Latina
ha ganado relevancia por su versatilidad. En este contexto, J7 SHS-P fue reconocido en Tailandia como The Best SUV PHEV in 2025, destacando su eficiencia energética y utilidad en el día a día. De forma paralela, en Malasia, JAECOO J7 recibió los premios Car of the Year 2025 – People's Choice
More news about: JAECOO
Dec 18, 2025, 09:52 ET Brasil é o primeiro país a aprovar imunobiológico para pacientes pediátricos com Urticária Crônica Espontânea
et al. Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials. J Allergy Clin Immunol. 2024 Jul;154(1):184-194.7 IQVIA/Sanofi Integrated DUPIXENT platform, data through August, 2024.
More news about: Sanofi
Dec 18, 2025, 09:42 ET A LG ajuda a salvar o Natal dos compradores de última hora com displays que guiam e encantam
37BH7N-H são perfeitos para instalar sobre gôndolas e corredores. A inspiração para a decisão é amplificada por magníficos painéis de Video Wall como o 55VSH7J-H, que criam murais imersivos, e pela tecnologia OLED Transparente (modelo 55EW5P-M), que eleva a experiência ao sobrepor animações a produtos de luxo.
More news about: LG Electronics Brasil
Dec 18, 2025, 09:40 ET Dr. Xavier D. Clark and Justin Insalaco to join VTP Leadership Solutions Executive Team
Justin onto our team reinforces what VTP Leadership Solutions stands for—bridging the gap between values, culture, and innovation," said Dr. Joseph J. Lestrange, Founder and CEO of VTP Leadership Solutions. "Dr. Clark brings a rare blend of organizational culture expertise and real-world experience
More news about: VTP Leadership Solutions
Dec 18, 2025, 08:32 ET Fusion Health 2025 Year in Review: Consistency, Delivery, and Purpose-Driven Expansion in Public-Sector Care
supports dependable workflows in secure settings.Bringing a practical voice to global conversationsIn February, Fusion CEO Bryan J. Jakovcic and COO Akanksha Karwar, MPH traveled to Bangkok for this year's International Corrections and Prisons Association Corrections Technology Conference,
More news about: Fusion Health
Dec 18, 2025, 08:15 ET NAFTZ Endorses Bill Aimed at Strengthening Manufacturers Operating in U.S. Foreign-Trade Zones
Jeffrey J. Tafel, president of NAFTZ. "Yet under USMCA, American manufacturers operating in FTZs are required to pay duties on imported components before exporting
More news about: National Association of Foreign-Trade Zones
Dec 18, 2025, 08:05 ET The Setai Expands Global Footprint with New Luxury Resort in St. Maarten, The Setai St. Maarten
thesetaihotel.com.The Setai Global Media Contact:J/[email protected] Setai St. Maarten
More news about: The Setai St. Maarten
Dec 18, 2025, 08:00 ET Novo Nordisk files for FDA approval of CagriSema, the first once-weekly combination of GLP‑1 and amylin analogues for weight management
cagrilintide and semaglutide in adults with overweight or obesity. N Engl J Med. 2025;393:635–647.Davies M, Bajaj H, Broholm C, et al. Cagrilintide–semaglutide in adults with overweight or obesity and type 2 diabetes. N Engl J Med. 2025;10.1056/NEJMoa2502082.ClinicalTrials.gov. REDEFINE
More news about: NOVO NORDISK INC.
Dec 18, 2025, 08:00 ET Novo Nordisk files for FDA approval of CagriSema, the first once-weekly combination of GLP‑1 and amylin analogues for weight management
cagrilintide and semaglutide in adults with overweight or obesity. N Engl J Med. 2025;393:635–647.Davies M, Bajaj H, Broholm C, et al. Cagrilintide–semaglutide in adults with overweight or obesity and type 2 diabetes. N Engl J Med. 2025;10.1056/NEJMoa2502082.ClinicalTrials.gov. REDEFINE
More news about: NOVO NORDISK INC.
Dec 18, 2025, 07:30 ET Positive Clinical Results from Phase 2 Trial of SGX945 for the Treatment of Behçet's Disease Published in Rheumatology (Oxford)
2a trial in aphthous ulcers of Behçet's Disease, enabling the medical community to evaluate this novel mechanism and therapeutic," stated Christopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix. "Given the role of the innate immune system, we believe that dusquetide may offer significant
More news about: SOLIGENIX, INC.